Tilray Brands (TLRY)
(Delayed Data from NSDQ)
$1.70 USD
0.00 (0.00%)
Updated Sep 10, 2024 04:00 PM ET
After-Market: $1.70 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth C Momentum C VGM
Price, Consensus and EPS Surprise
TLRY 1.70 0.00(0.00%)
Will TLRY be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for TLRY based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for TLRY
Tilray Brands, Inc. (TLRY) Flat As Market Gains: What You Should Know
Here's Why Tilray Brands, Inc. (TLRY) Fell More Than Broader Market
TLRY: What are Zacks experts saying now?
Zacks Private Portfolio Services
TLRY Grows Craft Beer Portfolio by Acquiring Molson Coors Brands
Tilray Brands, Inc. (TLRY) Trades Flat On The Day: What You Should Know
Tilray Brands, Inc. (TLRY) Beats Stock Market Upswing: What Investors Need to Know
Other News for TLRY
Last Call For SNDL's Liquor President: Stock On The Rocks Amid Leadership Changes
Canadian Cannabis LP Stocks Portfolio -10% W/e Sept. 6th
Tilray Medical Supports Scientific Study on Fibromyalgia With Positive Outcomes: Effectiveness of Cannabinoids Treatment in Pain Management and Other Fibromyalgia-Associated Symptoms
Look For Tilray To Keep Declining
Election 2024: Where To Put Your Money Ahead of the Vote